|
[1]
|
PGRMC1: An enigmatic heme-binding protein
Pharmacology & Therapeutics,
2023
DOI:10.1016/j.pharmthera.2022.108326
|
|
|
|
|
[2]
|
The role of progesterone and the progesterone receptor in cancer: progress in the last 5 years
Expert Review of Endocrinology & Metabolism,
2023
DOI:10.1080/17446651.2023.2166487
|
|
|
|
|
[3]
|
Insight into mitochondrial dysfunction mediated by clozapine-induced inhibition of PGRMC1 in PC12 cells
Toxicology,
2023
DOI:10.1016/j.tox.2023.153515
|
|
|
|
|
[4]
|
Reevaluating the Role of Progesterone in Ovarian Cancer: Is Progesterone Always Protective?
Endocrine Reviews,
2023
DOI:10.1210/endrev/bnad018
|
|
|
|
|
[5]
|
Pleiotropic Actions of PGRMC Proteins in Cancer
Endocrinology,
2022
DOI:10.1210/endocr/bqac078
|
|
|
|
|
[6]
|
Progesterone Receptor Membrane Component 1 and its Accomplice:
Emerging Therapeutic Targets in Lung Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets,
2022
DOI:10.2174/1871530321666211130145542
|
|
|
|
|
[7]
|
Structural characterisation of a
MAPR
‐related archaeal cytochrome
b
5M
protein
FEBS Letters,
2022
DOI:10.1002/1873-3468.14471
|
|
|
|
|
[8]
|
Progesterone Receptor Membrane Component 1 and its Accomplice:
Emerging Therapeutic Targets in Lung Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets,
2022
DOI:10.2174/1871530321666211130145542
|
|
|
|
|
[9]
|
Progesterone Receptor Membrane Component 1 and its Accomplice:
Emerging Therapeutic Targets in Lung Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets,
2022
DOI:10.2174/1871530321666211130145542
|
|
|
|
|
[10]
|
Loss of PGRMC1 Delays the Progression of Hepatocellular Carcinoma via Suppression of Pro-Inflammatory Immune Responses
Cancers,
2021
DOI:10.3390/cancers13102438
|
|
|
|
|
[11]
|
An Analysis of the Multifaceted Roles of Heme in the Pathogenesis of Cancer and Related Diseases
Cancers,
2021
DOI:10.3390/cancers13164142
|
|
|
|
|
[12]
|
AG-205 Upregulates Enzymes Involved in Cholesterol Biosynthesis and Steroidogenesis in Human Endometrial Cells Independently of PGRMC1 and Related MAPR Proteins
Biomolecules,
2021
DOI:10.3390/biom11101472
|
|
|
|
|
[13]
|
Therapeutic Targeting of Cancer Stem Cells in Lung, Head and Neck, and Bladder Cancers
Cancers,
2021
DOI:10.3390/cancers13205098
|
|
|
|
|
[14]
|
PGRMC1 Promotes Progestin-Dependent Proliferation of Breast Cancer Cells by Binding Prohibitins Resulting in Activation of ERα Signaling
Cancers,
2021
DOI:10.3390/cancers13225635
|
|
|
|
|
[15]
|
Progesterone Receptor Membrane Component (PGRMC)1 and PGRMC2 and Their Roles in Ovarian and Endometrial Cancer
Cancers,
2021
DOI:10.3390/cancers13235953
|
|
|
|
|
[16]
|
A Hypothetical Model Suggesting Some Possible Ways That the Progesterone Receptor May Be Involved in Cancer Proliferation
International Journal of Molecular Sciences,
2021
DOI:10.3390/ijms222212351
|
|
|
|
|
[17]
|
The PGRMC1 Antagonist AG-205 Inhibits Synthesis of Galactosylceramide and Sulfatide
Cells,
2021
DOI:10.3390/cells10123520
|
|
|
|
|
[18]
|
Gamma-ray irradiation modulates PGRMC1 expression and the number of CD56+ and FoxP3+ cells in the tumor microenvironment of endometrial endometrioid adenocarcinoma
Radiation Oncology Journal,
2021
DOI:10.3857/roj.2021.00472
|
|
|
|
|
[19]
|
Identification of PGRMC1 as a Candidate Oncogene for Head and Neck Cancers and Its Involvement in Metabolic Activities
Frontiers in Bioengineering and Biotechnology,
2020
DOI:10.3389/fbioe.2019.00438
|
|
|
|
|
[20]
|
Protein complexes including PGRMC1 and actin-associated proteins are disrupted by AG-205
Biochemical and Biophysical Research Communications,
2020
DOI:10.1016/j.bbrc.2019.12.108
|
|
|
|
|
[21]
|
Progesterone receptor membrane component 1 (PGRMC1) expression in canine mammary tumors: A preliminary study
Research in Veterinary Science,
2020
DOI:10.1016/j.rvsc.2020.06.004
|
|
|
|
|
[22]
|
Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression
Breast Cancer Research,
2020
DOI:10.1186/s13058-020-01312-8
|
|
|
|
|
[23]
|
PGRMC1 can trigger estrogen-dependent proliferation of breast cancer cells: estradiol vs. equilin vs. ethinylestradiol
Climacteric,
2019
DOI:10.1080/13697137.2019.1582624
|
|
|
|
|
[24]
|
Loss of progesterone receptor membrane component 1 promotes hepatic steatosis via the induced de novo lipogenesis
Scientific Reports,
2018
DOI:10.1038/s41598-018-34148-6
|
|
|
|
|
[25]
|
Loss of progesterone receptor membrane component 1 promotes hepatic steatosis via the induced de novo lipogenesis
Scientific Reports,
2018
DOI:10.1038/s41598-018-34148-6
|
|
|
|
|
[26]
|
The evolutionary appearance of signaling motifs in PGRMC1
BioScience Trends,
2017
DOI:10.5582/bst.2017.01009
|
|
|
|
|
[27]
|
Updates and current challenges in microRNA research for personalized medicine in ovarian cancer
Expert Opinion on Biological Therapy,
2017
DOI:10.1080/14712598.2017.1340935
|
|
|
|
|
[28]
|
The emerging role of progesterone receptor membrane component 1 (PGRMC1) in cancer biology
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer,
2016
DOI:10.1016/j.bbcan.2016.07.004
|
|
|
|